{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:32:48Z","timestamp":1790616768033,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T00:00:00Z","timestamp":1657670400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070588"],"award-info":[{"award-number":["82070588"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Southampton NIHR Biomedical Research Centre","award":["IS-BRC-20004"],"award-info":[{"award-number":["IS-BRC-20004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hepatol Int"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s12072-022-10384-x","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T15:04:09Z","timestamp":1657724649000},"page":"1085-1093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Low skeletal muscle mass is associated with more severe histological features of non-alcoholic fatty liver disease in male"],"prefix":"10.1007","volume":"16","author":[{"given":"Xiao-Yan","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Wu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-Jie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ou-Yang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Yang","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Dong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-2631","authenticated-orcid":false,"given":"Ming-Hua","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,13]]},"reference":[{"key":"10384_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology 2016;64:73\u201384","journal-title":"Hepatology"},{"key":"10384_CR2","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/apt.12046","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther 2012;36:815\u2013823","journal-title":"Aliment Pharmacol Ther"},{"key":"10384_CR3","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet 2021;397:2212\u20132224","journal-title":"Lancet"},{"key":"10384_CR4","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s12072-021-10252-0","volume":"15","author":"HH Liu","year":"2021","unstructured":"Liu HH, Cao YX, Jin JL, Guo YL, Zhu CG, Wu NQ, et al. Metabolic-associated fatty liver disease and major adverse cardiac events in patients with chronic coronary syndrome: a matched case-control study. Hepatol Int 2021;15:1337\u20131346","journal-title":"Hepatol Int"},{"key":"10384_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154433","volume":"115","author":"DQ Sun","year":"2021","unstructured":"Sun DQ, Jin Y, Wang TY, Zheng KI, Rios RS, Zhang HY, et al. MAFLD and risk of CKD. Metabolism 2021;115: 154433","journal-title":"Metabolism"},{"key":"10384_CR6","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41581-021-00519-y","volume":"18","author":"TY Wang","year":"2022","unstructured":"Wang TY, Wang RF, Bu ZY, Targher G, Byrne CD, Sun DQ, et al. Association of metabolic dysfunction-associated fatty liver disease with kidney disease. Nat Rev Nephrol 2022;18:259\u2013268","journal-title":"Nat Rev Nephrol"},{"key":"10384_CR7","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 2019;48:16\u201331","journal-title":"Age Ageing"},{"key":"10384_CR8","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/apt.13549","volume":"43","author":"M Sinclair","year":"2016","unstructured":"Sinclair M, Gow PJ, Grossmann M, Angus PW. Review article: sarcopenia in cirrhosis\u2013aetiology, implications and potential therapeutic interventions. Aliment Pharmacol Ther 2016;43:765\u2013777","journal-title":"Aliment Pharmacol Ther"},{"key":"10384_CR9","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1002\/hep.26716","volume":"59","author":"HC Hong","year":"2014","unstructured":"Hong HC, Hwang SY, Choi HY, Yoo HJ, Seo JA, Kim SG, et al. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic obesity study. Hepatology 2014;59:1772\u20131778","journal-title":"Hepatology"},{"key":"10384_CR10","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1002\/hep.28376","volume":"63","author":"YH Lee","year":"2016","unstructured":"Lee YH, Kim SU, Song K, Park JY, Kim DY, Ahn SH, et al. Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: nationwide surveys (KNHANES 2008\u20132011). Hepatology 2016;63:776\u2013786","journal-title":"Hepatology"},{"key":"10384_CR11","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.jhep.2015.02.051","volume":"63","author":"YH Lee","year":"2015","unstructured":"Lee YH, Jung KS, Kim SU, Yoon HJ, Yun YJ, Lee BW, et al. Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008\u20132011). J Hepatol 2015;63:486\u2013493","journal-title":"J Hepatol"},{"key":"10384_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.jhep.2016.08.019","volume":"66","author":"BK Koo","year":"2017","unstructured":"Koo BK, Kim D, Joo SK, Kim JH, Chang MS, Kim BG, et al. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis. J Hepatol 2017;66:123\u2013131","journal-title":"J Hepatol"},{"key":"10384_CR13","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1111\/apt.13889","volume":"45","author":"S Petta","year":"2017","unstructured":"Petta S, Ciminnisi S, Di Marco V, Cabibi D, Camma C, Licata A, et al. Sarcopenia is associated with severe liver fibrosis in patients with non-alcoholic fatty liver disease. Aliment Pharmacol Ther 2017;45:510\u2013518","journal-title":"Aliment Pharmacol Ther"},{"key":"10384_CR14","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jhep.2020.03.006","volume":"73","author":"Z Liu","year":"2020","unstructured":"Liu Z, Zhang Y, Graham S, Wang X, Cai D, Huang M, et al. Causal relationships between NAFLD, T2D and obesity have implications for disease subphenotyping. J Hepatol 2020;73:263\u2013276","journal-title":"J Hepatol"},{"key":"10384_CR15","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.jhep.2017.11.038","volume":"68","author":"PJ Meffert","year":"2018","unstructured":"Meffert PJ, Repp KD, Volzke H, Weiss FU, Homuth G, Kuhn JP, et al. The PNPLA3 SNP rs738409: G allele is associated with increased liver disease-associated mortality but reduced overall mortality in a population-based cohort. J Hepatol 2018;68:858\u2013860","journal-title":"J Hepatol"},{"key":"10384_CR16","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1007\/s00125-018-4805-x","volume":"62","author":"MF Xia","year":"2019","unstructured":"Xia MF, Lin HD, Chen LY, Wu L, Ma H, Li Q, et al. The PNPLA3 rs738409 C\u00a0>\u00a0G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetes. Diabetologia 2019;62:644\u2013654","journal-title":"Diabetologia"},{"key":"10384_CR17","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1111\/apt.15372","volume":"50","author":"MF Xia","year":"2019","unstructured":"Xia MF, Chen LY, Wu L, Ma H, Li Q, Aleteng Q, et al. The PNPLA3 rs738409 C\u00a0>\u00a0G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng study. Aliment Pharmacol Ther 2019;50:684\u2013695","journal-title":"Aliment Pharmacol Ther"},{"key":"10384_CR18","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/jgh.14894","volume":"35","author":"WY Liu","year":"2020","unstructured":"Liu WY, Zheng KI, Pan XY, Ma HL, Zhu PW, Wu XX, et al. Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2020;35:1057\u20131064","journal-title":"J Gastroenterol Hepatol"},{"key":"10384_CR19","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412\u2013419","journal-title":"Diabetologia"},{"key":"10384_CR20","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1002\/hep.20701","volume":"41","author":"DE Kleiner","year":"2005","unstructured":"Kleiner DE, Brunt EM, Van Natta M, Behling C, Contos MJ, Cummings OW, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41:1313\u20131321","journal-title":"Hepatology"},{"issue":"1","key":"10384_CR21","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3390\/ijms17010097","volume":"17","author":"EM Brunt","year":"2016","unstructured":"Brunt EM. Nonalcoholic fatty liver disease: pros and cons of histologic systems of evaluation. Int J Mol Sci 2016;17(1):97","journal-title":"Int J Mol Sci"},{"key":"10384_CR22","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1002\/hep.29420","volume":"66","author":"RA Bhanji","year":"2017","unstructured":"Bhanji RA, Narayanan P, Allen AM, Malhi H, Watt KD. Sarcopenia in hiding: the risk and consequence of underestimating muscle dysfunction in nonalcoholic steatohepatitis. Hepatology 2017;66:2055\u20132065","journal-title":"Hepatology"},{"key":"10384_CR23","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/j.clnu.2019.04.023","volume":"39","author":"D Gan","year":"2020","unstructured":"Gan D, Wang L, Jia M, Ru Y, Ma Y, Zheng W, et al. Low muscle mass and low muscle strength associate with nonalcoholic fatty liver disease. Clin Nutr 2020;39:1124\u20131130","journal-title":"Clin Nutr"},{"key":"10384_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/liv.14253","volume":"40","author":"M Tanaka","year":"2020","unstructured":"Tanaka M, Okada H, Hashimoto Y, Kumagai M, Nishimura H, Oda Y, et al. Relationship between nonalcoholic fatty liver disease and muscle quality as well as quantity evaluated by computed tomography. Liver Int 2020;40:120\u2013130","journal-title":"Liver Int"},{"key":"10384_CR25","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1159\/000491015","volume":"36","author":"X Pan","year":"2018","unstructured":"Pan X, Han Y, Zou T, Zhu G, Xu K, Zheng J, et al. Sarcopenia contributes to the progression of nonalcoholic fatty liver disease- related fibrosis: a meta-analysis. Dig Dis 2018;36:427\u2013436","journal-title":"Dig Dis"},{"key":"10384_CR26","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/hepr.13321","volume":"49","author":"Y Seko","year":"2019","unstructured":"Seko Y, Mizuno N, Okishio S, Takahashi A, Kataoka S, Okuda K, et al. Clinical and pathological features of sarcopenia-related indices in patients with non-alcoholic fatty liver disease. Hepatol Res 2019;49:627\u2013636","journal-title":"Hepatol Res"},{"key":"10384_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1111\/jgh.12656","volume":"30","author":"J Shen","year":"2015","unstructured":"Shen J, Wong GL, Chan HL, Chan RS, Chan HY, Chu WC, et al. PNPLA3 gene polymorphism and response to lifestyle modification in patients with nonalcoholic fatty liver disease. J Gastroenterol Hepatol 2015;30:139\u2013146","journal-title":"J Gastroenterol Hepatol"},{"key":"10384_CR28","doi-asserted-by":"publisher","first-page":"67","DOI":"10.5009\/gnl18070","volume":"13","author":"MJ Lee","year":"2019","unstructured":"Lee MJ, Kim EH, Bae SJ, Kim GA, Park SW, Choe J, et al. Age-related decrease in skeletal muscle mass is an independent risk factor for incident nonalcoholic fatty liver disease: a 10-year retrospective cohort study. Gut Liver 2019;13:67\u201376","journal-title":"Gut Liver"},{"key":"10384_CR29","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1002\/hep.30049","volume":"68","author":"G Kim","year":"2018","unstructured":"Kim G, Lee SE, Lee YB, Jun JE, Ahn J, Bae JC, et al. Relationship between relative skeletal muscle mass and nonalcoholic fatty liver disease: a 7-year longitudinal study. Hepatology 2018;68:1755\u20131768","journal-title":"Hepatology"},{"key":"10384_CR30","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1038\/ajg.2015.235","volume":"110","author":"JL Wei","year":"2015","unstructured":"Wei JL, Leung JC, Loong TC, Wong GL, Yeung DK, Chan RS, et al. Prevalence and severity of nonalcoholic fatty liver disease in non-obese patients: a population study using proton-magnetic resonance spectroscopy. Am J Gastroenterol 2015;110:1306\u20131314","journal-title":"Am J Gastroenterol"},{"key":"10384_CR31","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.diabet.2019.10.004","volume":"46","author":"DH Seo","year":"2020","unstructured":"Seo DH, Lee YH, Park SW, Choi YJ, Huh BW, Lee E, et al. Sarcopenia is associated with non-alcoholic fatty liver disease in men with type 2 diabetes. Diabetes Metab 2020;46:362\u2013369","journal-title":"Diabetes Metab"},{"key":"10384_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1507\/endocrj.EJ16-0124","volume":"63","author":"Y Hashimoto","year":"2016","unstructured":"Hashimoto Y, Osaka T, Fukuda T, Tanaka M, Yamazaki M, Fukui M. The relationship between hepatic steatosis and skeletal muscle mass index in men with type 2 diabetes. Endocr J 2016;63:877\u2013884","journal-title":"Endocr J"},{"key":"10384_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/978-3-319-70178-3_2","volume":"1043","author":"MA Bredella","year":"2017","unstructured":"Bredella MA. Sex differences in body composition. Adv Exp Med Biol 2017;1043:9\u201327","journal-title":"Adv Exp Med Biol"},{"key":"10384_CR34","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1146\/annurev-nutr-071715-050901","volume":"36","author":"BJ Gheller","year":"2016","unstructured":"Gheller BJ, Riddle ES, Lem MR, Thalacker-Mercer AE. Understanding age-related changes in skeletal muscle metabolism: differences between females and males. Annu Rev Nutr 2016;36:129\u2013156","journal-title":"Annu Rev Nutr"},{"key":"10384_CR35","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1038\/ejcn.2017.27","volume":"71","author":"A Bosy-Westphal","year":"2017","unstructured":"Bosy-Westphal A, Jensen B, Braun W, Pourhassan M, Gallagher D, Muller MJ. Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices. Eur J Clin Nutr 2017;71:1061\u20131067","journal-title":"Eur J Clin Nutr"},{"key":"10384_CR36","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/jgh3.12289","volume":"4","author":"T Kuwashiro","year":"2020","unstructured":"Kuwashiro T, Takahashi H, Hyogo H, Ogawa Y, Imajo K, Yoneda M, et al. Discordant pathological diagnosis of non-alcoholic fatty liver disease: a prospective multicenter study. JGH Open 2020;4:497\u2013502","journal-title":"JGH Open"},{"issue":"6","key":"10384_CR37","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/jgh.15843","volume":"37","author":"HH Leung","year":"2022","unstructured":"Leung HH, Puspanathan P, Chan AW, Nik Mustapha NR, Wong VW, Chan WK. Reliability of the nonalcoholic steatohepatitis clinical research network and steatosis activity fibrosis histological scoring systems. J Gastroenterol Hepatol 2022;37(6):1131\u20131138","journal-title":"J Gastroenterol Hepatol"}],"container-title":["Hepatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12072-022-10384-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12072-022-10384-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,30]],"date-time":"2022-09-30T07:33:57Z","timestamp":1664523237000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12072-022-10384-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,13]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["10384"],"URL":"https:\/\/doi.org\/10.1007\/s12072-022-10384-x","relation":{},"ISSN":["1936-0533","1936-0541"],"issn-type":[{"value":"1936-0533","type":"print"},{"value":"1936-0541","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,13]]},"assertion":[{"value":"22 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors (Xiao-Yan Pan, Wen-Yue Liu, Pei-Wu Zhu, Gang Li, Liang-Jie Tang, Feng Gao, Ou-Yang Huang, Hai-Yang Yuan, Giovanni Targher, Christopher D. Byrne, Xiao-Dong Wang, Ming-Hua Zheng) declare that they do not have anything to disclose regarding any funding or conflict of interest with respect to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval for the study was obtained from the ethics committee of the First Affiliated Hospital of Wenzhou Medical University. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki Declaration and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}